1. Home
  2. CERS vs GEOS Comparison

CERS vs GEOS Comparison

Compare CERS & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • GEOS
  • Stock Information
  • Founded
  • CERS 1991
  • GEOS 1980
  • Country
  • CERS United States
  • GEOS United States
  • Employees
  • CERS N/A
  • GEOS N/A
  • Industry
  • CERS EDP Services
  • GEOS Industrial Machinery/Components
  • Sector
  • CERS Technology
  • GEOS Industrials
  • Exchange
  • CERS Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • CERS 276.0M
  • GEOS 249.9M
  • IPO Year
  • CERS 1997
  • GEOS 1997
  • Fundamental
  • Price
  • CERS $1.69
  • GEOS $12.12
  • Analyst Decision
  • CERS Buy
  • GEOS
  • Analyst Count
  • CERS 1
  • GEOS 0
  • Target Price
  • CERS $4.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • CERS 1.3M
  • GEOS 256.3K
  • Earning Date
  • CERS 11-06-2025
  • GEOS 11-20-2025
  • Dividend Yield
  • CERS N/A
  • GEOS N/A
  • EPS Growth
  • CERS N/A
  • GEOS N/A
  • EPS
  • CERS N/A
  • GEOS N/A
  • Revenue
  • CERS $199,191,000.00
  • GEOS $110,803,000.00
  • Revenue This Year
  • CERS $19.07
  • GEOS N/A
  • Revenue Next Year
  • CERS $12.03
  • GEOS N/A
  • P/E Ratio
  • CERS N/A
  • GEOS N/A
  • Revenue Growth
  • CERS 13.03
  • GEOS N/A
  • 52 Week Low
  • CERS $1.12
  • GEOS $5.51
  • 52 Week High
  • CERS $2.24
  • GEOS $29.89
  • Technical
  • Relative Strength Index (RSI)
  • CERS 59.26
  • GEOS 21.61
  • Support Level
  • CERS $1.47
  • GEOS $24.01
  • Resistance Level
  • CERS $1.78
  • GEOS $28.77
  • Average True Range (ATR)
  • CERS 0.13
  • GEOS 2.29
  • MACD
  • CERS 0.01
  • GEOS -1.72
  • Stochastic Oscillator
  • CERS 78.75
  • GEOS 0.99

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: